Research & Reviews: A Journal of Toxicology

ISSN: 2231-3834

Editors Overview

rrjot maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue
Topic

Application of Snake Venom in Cancer

Abstract Submission Deadline : November 30, 2023

Manuscript Submission Deadline : December 25, 2023

Special Issue Description

Cancer is one of the driving causes of horribleness and mortality around the world, and the disclosure of unused drugs for cancer treatment is one of the foremost imperative goals for the pharmaceutical industry. Surgery and chemotherapy are still the most techniques for cancer treatment. Target treatment, which Meddling with a particular atomic target, which ordinarily causes fewer toxicities, is becoming increasingly prevalent in chemotherapy. As of late, the compounds decontaminated and characterized by snake venom have shown huge potential as operators focusing on molecular pathways in cancer cells. Snake venoms are complex blends of proteins, peptides, and other bioactive particles emitted by the poisonous organ of snakes and infused by the interesting teeth of snakes to weaken and process their prey. The different clinical signs of snakebite casualties are caused by the exceedingly complex and different compositions of wind venoms, which can specifically recognize their distinctive natural targets. Captopril, the first angiotensin-converting protein inhibitor affirmed in 1981 by the FDA, was outlined based on the structure of a peptide separated from the wind poison. The application of the snake venoms in cancer treatment has advanced from the utilization of the rough blends within the 1930s into the segregation of certain organically dynamic components focusing on molecular pathways. Right now, the combination of snake venoms with other innovations such as nanoparticles is still in its early stages for cancer treatment, and it can be anticipated that more combinational treatments will develop. Snake venoms are no doubt important assets for cancer drug advancement.

Keywords

Snake Venom, Cancer, Mortality, Drug, Molecular Pathway

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals:

Abbrivation


rrjot

Since

2010

APC

950 $